Identification of Novel DNA Methylation Prognostic Biomarkers for AML With Normal Cytogenetics.
Cândida CardosoDaniel PestanaSreemol GokuladhasAna D MarreirosJustin Martin O'SullivanAlexandra BinnieMónica TFernandesPedro Castelo-BrancoPublished in: JCO clinical cancer informatics (2024)
This study highlights DNA methylation profiling as a promising approach to enhance risk stratification in patients with CN-AML, potentially offering a pathway to more personalized treatment strategies.